Cargando…
Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575575/ https://www.ncbi.nlm.nih.gov/pubmed/34804851 http://dx.doi.org/10.21037/tau-2021-06 |
| _version_ | 1784595701750038528 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8575575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85755752021-11-18 Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients Transl Androl Urol Erratum AME Publishing Company 2021-10 /pmc/articles/PMC8575575/ /pubmed/34804851 http://dx.doi.org/10.21037/tau-2021-06 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Erratum Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title | Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title_full | Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title_fullStr | Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title_full_unstemmed | Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title_short | Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| title_sort | erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575575/ https://www.ncbi.nlm.nih.gov/pubmed/34804851 http://dx.doi.org/10.21037/tau-2021-06 |
| work_keys_str_mv | AT erratumtohormonalmanipulationinandrogensignalinganarrativereviewonusingnovelandrogentherapyagentstooptimizeclinicaloutcomesandminimizesideeffectsforprostatecancerpatients |